Skip to main content



) -- Several stocks trading near $5 were poised to move on above-average volume during Friday's session.

Cytori Therapeutics


jumped by 96 cents, or 14.8%, to $7.44 in the premarket session after the company said the Food and Drug Administration granted a 510(k) marketing clearance for its PureGraft System, allowing Cytori to launch the first and only body-contouring device in the U.S. cleared to use a patient's own fat tissue. The 50-day average daily volume for Cytori is 634,000, according to the



Allos Therapeutics


tacked on 9 cents, or 1.3%, to $6.82 in Friday's premarket session after JPMorgan Chase analysts initiated coverage of the stock with an overweight rating. The 50-day average daily volume for Allos is 1.89 million.

Luna Innovations

(LUNA) - Get Free Report

rallied by 65 cents, or 24.8%, to $3.27 in the premarket session after the company said it will be extending its development and supply agreement with

Intuitive Surgical

(ISRG) - Get Free Report

to further develop Luna's technology for Intuitive's products. The 50-day average daily volume for Luna is 128,000.



surged by $1.30, or 44.1%, to $4.25 in the premarket session after the company's Zargis Medical subsidiary announced that Health Canada has cleared the Zargis Cardioscan device for sale in Canada. The 50-day average daily volume for Speedus is 21,000.


Earlier at 7:50 a.m. EST


I.D. Systems


is expected to trade higher Friday after the company said it has acquired the Asset Intelligence business unit of

General Electric

(GE) - Get Free Report

, for $15 million in cash, with an additional cash consideration of up to $2 million payable upon the achievement of certain performance milestones. The 50-day average daily volume for I.D. Systems is 30,000, according to the



Cyclacel Pharmaceuticals

(CYCC) - Get Free Report

continued to rally after. On Thursday, the stock surged 152% after


said two peer-reviewed journal articles showed that the company's seliciclib drug candidate was found effective against lung cancer cell lines, including K-RAS protein mutations. The 50-day average daily volume for Cyclacel is 1.95 million shares.

Nu Horizons Electronics


shares were indicated higher after the company late Thursday posted a third-quarter profit of 4 cents a share, coming in well ahead of the lone analyst estimate of a penny a share, according to Thomson Reuters. The 50-day average daily volume for Nu Horizons is 45,000.

Synta Pharmaceuticals


traded lower in Thursday's after-market session following its announcement it is planning a common stock offering of 4 million shares. The company said the offering would price Friday before the start of trading. The 50-day average daily volume for Synta is 114,000 shares.

Lawson Software


was set to trade down Friday after posting fiscal second-quarter results. Although the company met earnings targets and exceeded expectations with revenue in the quarter, Lawson disappointed with weak earnings guidance for its fiscal third quarter. The company expects adjusted earnings to fall between 7 cents and 9 cents a share, below the Thomson Reuters average estimate of 10 cents a share. The 50-day average daily volume for Lawson is 997,000.

-- Written by Robert Holmes in Boston


Check out all of Friday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on


and become a fan of on